Literature DB >> 6677168

[Anti-edematous action of a hexane extract of the stone fruit of Serenoa repens Bartr].

J P Tarayre, A Delhon, H Lauressergues, A Stenger, M Barbara, M Bru, G Villanova, V Caillol, M Aliaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6677168

Source DB:  PubMed          Journal:  Ann Pharm Fr        ISSN： 0003-4509


× No keyword cloud information.
  5 in total

1.  Serenoa repens extract in the treatment of benign prostatic hyperplasia.

Authors:  Petrisor Geavlete; Razvan Multescu; Bogdan Geavlete
Journal:  Ther Adv Urol       Date:  2011-08

Review 2.  Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

3.  Distribution study of radioactivity in rats after oral administration of the lipido/sterolic extract of Serenoa repens (Permixon) supplemented with [1-14C]-lauric acid, [1-14C]-oleic acid or [4-14C]-beta-sitosterol.

Authors:  G Chevalier; P Benard; H Cousse; T Bengone
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.441

4.  Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure.

Authors:  Paolo Governa; Daniela Giachetti; Marco Biagi; Fabrizio Manetti; Luca De Vico
Journal:  PeerJ       Date:  2016-11-22       Impact factor: 2.984

5.  Inhibitory effects of Serenoa repens on the kinetic of pig prostatic microsomal 5alpha-reductase activity.

Authors:  M F Palin; M Faguy; J G LeHoux; G Pelletier
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.925
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.